Ancillary Evaluation Of Systemic Immune Antitumour Response (Siar) And Tumour Growth Rate (Tgr) Of Patients (Pts) With Metastatic Melanoma (Mm) Treated With Radiotherapy (Rt) Combined With Ipilimumab (Ipi) In The Phase I Study Mel-Ipi-Rx
ANNALS OF ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要